Pharmacologic therapy for the neurogenic bladder.
This article is a review of the current and past literature on medical management of the neurogenic bladder, with a particular focus on spinal cord injury and multiple sclerosis. The use of antimuscarinics, αα-blocker, and tricyclic antidepressants and their combined use are discussed along with new therapies in human and animal trials.
Cameron
Anne P
AP
Department of Urology, University of Michigan, 3875 Taubman Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-5330, USA. annepell@med.umich.edu
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D018680:Cholinergic Antagonists / Q000494:pharmacology; D004359:Drug Therapy, Combination; D006801:Humans; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy*
D000317:Adrenergic alpha-Antagonists; D018680:Cholinergic Antagonists